Ubiquigent
Business Services · Mississippi, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
James Lindsay Pl, Dundee, Mississippi, 3...Phone Number
(617) 245-0020Website
www.ubiquigent.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Ubiquigent
Ubiquigent specializes in the discovery and development of DUB enzymes and the ubiquitin-proteasome system. The company has a strong track record and offers a unique range of specialist services. However, Ubiquigent is currently in the process of transferring its brand to a new owner and is no longer providing access to its reagents or services. Future support for ubiquitin-proteasome system research may be available from the new owner.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ubiquigent your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Ubiquigent, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Ubiquigent had a recent Job posting/layoffs
Earning: See what the market has to say on Ubiquigent recently announced quarterly report
Product Launch: Get notified when Ubiquigent launches new products
Congratulate Masked Content for being promoted to Masked Content at Ubiquigent
Funding: Get notified immidiatlly once Ubiquigent has new funding data
Check if Ubiquigent has recently received funding, and reach out quickly before it becomes old news!
Check out if Ubiquigent is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Ubiquigent
Compare insights from companies similar to Ubiquigent, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Ubiquigent
<$5M
1-10
Private
<$5M
2009
N/A
Company Profile Activity
Activity Insights
Ubiquigent is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Ubiquigent is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Ubiquigent.
Ubiquigent financials insights
Gather financial insights about Ubiquigent, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Unspecified
$808K
Ubiquigent Tech Stack
A closer look at the technologies used by Ubiquigent
Ubiquigent News & Media
Ubiquigent and Debiopharm Enter Agreement to Support USP1 Inhibitor Programme for Debio 0432
DUNDEE, Scotland & LAUSANNE, Switzerland--(BUSINESS WIRE)--Ubiquigent Limited (Ubiquigent), a drug discovery and development company harnessing novel deubiquitinase (DUB) modulators as new therapeutics for areas of high unmet medical need, today announced an agreement with Debiopharm, a biopharmaceutical company aiming to develop tomorrow’s standard-of-care treatments to cure cancer and infectious diseases. The agreement will support the development of Debiopharm’s USP1 inhibitor programme, DebUbiquigent Enters Agreement With Astellas Subsidiary, Nanna Therapeutics
DUNDEE, Scotland--(BUSINESS WIRE)--Ubiquigent Limited (Ubiquigent), a drug discovery and development company harnessing novel deubiquitinase (DUB) modulators as new therapeutics for areas of high unmet medical need, today announced an agreement with Nanna Therapeutics (Nanna). Under the terms of the agreement, Ubiquigent will provide Nanna with access to its deubiquitylase (DUB) focused drug discovery platform to support the development of novel therapeutics for human disease targets selected bUbiquigent appoints Dr Rishi Shah as Head of Chemistry
Ubiquigent Limited, a drug discovery and development company harnessing novel deubiquitinase (DUB) modulators as new therapeutics for areas of high unmet medical need, have announced the appointment of Dr Rishi Shah as Head of Chemistry.Ubiquigent celebrates milestone anniversary of DUBprofiler™ compound profiling platform
DUNDEE, Scotland--(BUSINESS WIRE)-- #Biotechnology--Ubiquigent celebrates the milestone anniversary of its highly cited and comprehensive enzyme profiling platform, DUBprofiler™.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Ubiquigent
Sign Up For FreeTo access detailed company insights
Ubiquigent specializes in the discovery and development of DUB enzymes and the ubiquitin-proteasome system. The company has a strong track record and offers a unique range of specialist services. However, Ubiquigent is currently in the process of transferring its brand to a new owner and is no longer providing access to its reagents or services. Fu... Read More
